Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,815,400
+$264,431 QoQ
Shares Held
10,055
+5.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#327
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $768,194,500 across 15 Diagnostics & Research names. LH ranks #13 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,625,814 | $309,685,049 | |
| 2 | A |
Agilent Technologies, Inc.
|
1,407,227 | $186,921,961 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
310,006 | $155,424,606 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
117,970 | $22,794,162 | |
| 5 | NTRA |
Natera, Inc.
|
74,780 | $20,299,030 | |
| 6 | ILMN |
Illumina, Inc.
|
80,373 | $14,131,984 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
24,835 | $13,152,367 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
24,601 | $12,950,949 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,815,400 | 10,055 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,550,969 | 9,561 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,560,229 | 10,205 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,061,207 | 10,664 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,975,812 | 11,336 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,519,028 | 15,120 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,008,448 | 13,119 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,099,220 | 13,868 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $2,681,039 | 13,174 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||